Premium
Ethical Issues Related to Clinical, Translational, and Health System Research
Author(s) -
Klepser Michael E.,
Matzke Gary R.,
Vivian Eva,
Granberry Mark,
Majerus Thomas,
Wiggins Barbara,
HillZabala Christina,
Weimert Nicole,
Raebel Marsha A.
Publication year - 2008
Publication title -
pharmacotherapy: the journal of human pharmacology and drug therapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.227
H-Index - 109
eISSN - 1875-9114
pISSN - 0277-0008
DOI - 10.1592/phco.28.11.1421
Subject(s) - objectivity (philosophy) , engineering ethics , pharmacy , medicine , biobank , research integrity , scientific integrity , translational research , medical education , family medicine , pathology , epistemology , engineering , philosophy , biology , genetics
In 2005, a charge was created to update the the American College of Clinical Pharmacy's 1993 white paper on Ethical Issues in Clinical Pharmacy Research. In that paper, emerging threats to scientific integrity were identified, and guidance was provided to investigators to minimize their risk for impropriety. The committee charged with this task considered a variety of issues pertaining to research, including those that are related to patients, pharmacogenomics, economics, and study design and oversight. Objectivity and integrity are the foundations on which all researchers should base their scientific endeavors. One's desire for acclaim, promotion, or financial reward must be closely monitored so that these factors do not impair a researcher's judgment and objectivity. The ethical line can become easily blurred. Therefore, the constructs of scientific integrity should be integral to pharmacy education and scientific training programs, and their principles applied throughout one's career.